311 studies found for:    Endometrial Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Unknown  Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Conditions: Endometrial Cancer;   Fatigue;   Neurotoxicity
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Radiation: brachytherapy;   Radiation: intensity-modulated radiation therapy;   Radiation: radiation therapy
22 Completed Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition: Recurrent Endometrial Carcinoma
Interventions: Drug: gefitinib;   Other: laboratory biomarker analysis
23 Active, not recruiting Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Conditions: Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Drug: cisplatin;   Drug: paclitaxel;   Drug: carboplatin;   Radiation: brachytherapy
24 Completed
Has Results
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Conditions: Breast Cancer;   Drug/Agent Toxicity by Tissue/Organ;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Dietary Supplement: pyridoxine hydrochloride;   Drug: Placebo;   Drug: doxorubicin HCL liposome
25 Terminated Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: conjugated estrogens
26 Completed S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: paclitaxel
27 Active, not recruiting Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer;   Uterine Cervical Cancer
Interventions: Drug: Filgrastim;   Drug: Paclitaxel;   Drug: Carboplatin
28 Recruiting Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Abdominal total hysterectomy;   Procedure: Robot assisted laparoscopic hysterectomy
29 Active, not recruiting Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Conditions: Endometrial Adenoacanthoma;   Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Endometrial Stromal Sarcoma;   Recurrent Endometrial Carcinoma
Intervention: Biological: trebananib
30 Completed
Has Results
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Conditions: Neoplasms;   Neoplasms by Site;   Urogenital Neoplasms;   Genital Neoplasms, Female;   Uterine Neoplasms;   Endometrial Neoplasms;   Cancer of Endometrium;   Endometrial Cancer;   Cancer of the Endometrium;   Endometrium Cancer;   Neoplasms, Endometrial
Intervention: Drug: pemetrexed
31 Recruiting Tachosil for the Prevention of Symptomatic Lymph Cysts
Conditions: Endometrial Cancer;   Cervical Cancer
Intervention: Drug: Tachosil fibrin patch
32 Recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Adenoacanthoma;   Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma
Interventions: Radiation: brachytherapy;   Radiation: 3-dimensional conformal radiation therapy;   Drug: cisplatin
33 Unknown  Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: aminopterin
34 Active, not recruiting Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Extensive Stage Small Cell Lung Cancer;   Hereditary Paraganglioma;   Male Breast Cancer;   Malignant Paraganglioma;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Pheochromocytoma;   Pancreatic Polypeptide Tumor;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Neuroendocrine Carcinoma of the Skin;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pheochromocytoma;   Recurrent Prostate Cancer;   Recurrent Renal Cell Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Uterine Sarcoma;   Regional Gastrointestinal Carcinoid Tumor;   Regional Pheochromocytoma;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage III Uterine Sarcoma;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Neuroendocrine Carcinoma of the Skin;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: temsirolimus;   Drug: vinorelbine ditartrate
35 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: cisplatin;   Drug: paclitaxel;   Procedure: adjuvant therapy;   Radiation: radiation therapy
36 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Procedure: adjuvant therapy;   Radiation: radiation therapy
37 Recruiting Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms
Conditions: Breast Cancer;   Endometrial Cancer
Interventions: Other: HLA vaginal gel (HyaloGYN®),;   Behavioral: questionnaires
38 Completed Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
39 Unknown  Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
40 Completed
Has Results
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Radiation: radiation therapy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years